Ignite Creation Date:
2025-12-24 @ 6:43 PM
Ignite Modification Date:
2025-12-29 @ 11:54 PM
Study NCT ID:
NCT00749957
Status:
COMPLETED
Last Update Posted:
2017-12-28
First Post:
2008-09-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 1/2 Safety and Efficacy Study of AAV-RPE65 Vector to Treat Leber Congenital Amaurosis
Sponsor:
Beacon Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-06-17
Start Date Type:
ACTUAL
Primary Completion Date:
2014-09-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-09-22
Completion Date Type:
ACTUAL
First Submit Date:
2008-09-08
First Submit QC Date:
None
Study First Post Date:
2008-09-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-11-30
Results First Submit QC Date:
None
Results First Post Date:
2016-04-08
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-12-01
Last Update Post Date:
2017-12-28
Last Update Post Date Type:
ACTUAL